Government seeks industry comment on expediting medical product development -

The U.S. Department of Health and Human Services' (HHS) Immediate Office of the Secretary (IOS) has announced it will hold a public meeting 20-21 June to seek public input and comment on ways the department can help shorten the time needed for safe and effective medical products to go from discovery to patient use. For example, pharmaceutical companies and medical device manufacturers may want to encourage HHS to develop a database of clinical evidence for newly cleared or approved products, which commercial payers can reference when making coverage decisions. This meeting is part of the ReImagine HHS: Accelerate Clinical Innovation (ACI) initiative, which is examining the entire medical innovation process at an enterprise level to identify new ways for patients to have timely access to new medical products.